Rasilez HCT(R), Single-pill Combination Of Rasilez(R) And Diuretic, Receives Swiss Approval For The Treatment Of High Blood Pressure

Rasilez HCT® (aliskiren and hydrochlorothiazide), a single-pill combination of two high blood pressure medicines - first-in-class direct renin inhibitor Rasilez®[1] (aliskiren) and the diuretic hydrochlorothiazide (HCT) - has been approved by Swissmedic as a new treatment for high blood pressure. High blood pressure is estimated to affect nearly one in four adults worldwide3.

More: continued here

Filed under: Hypertension on October 29th, 2008